Gyros Protein Technologies Solutions for Protein Analysis and Biopharmaceutical Development

Gyros Protein Technologies is a global leader in advanced protein analysis and bioanalytical solutions, dedicated to accelerating research and improving the development of innovative therapies. Formed through the merger of Gyros AB and Protein Technologies, the company brings decades of experience supporting research laboratories, biopharmaceutical companies, and clinical development centers worldwide.

Specializing in technologies for immunoassays and peptide synthesis, Gyros Protein Technologies delivers solutions for drug discovery, bioanalytical development and quality control, and biomarker analysis. The Gyrolab™ platforms enable miniaturized, automated immunoassays with high reproducibility and low sample consumption, while PurePep® systems ensure efficient and reliable peptide synthesis for research.

The company provides automated systems, dedicated software, and integrated workflows that help laboratories generate fast, accurate, and reproducible results. These solutions are designed to improve operational efficiency and support critical decision-making in the development of new drugs and biologic therapies.

Choosing operational lease for Gyros Protein Technologies’ solutions can offer significant benefits, including access to state-of-the-art technologies without large upfront investments, improved cost control, and the flexibility to upgrade platforms over time. In addition, potential tax advantages may further support the financial sustainability of life science organizations.